- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07326501
Attitudes and Perceptions of Corresponding Authors From Top International Medical Journals Regarding the Use of Artificial Intelligence in the Scientific Process (AISurvey6 A+)
December 24, 2025 updated by: Centre Hospitalier Universitaire de Nice
"Artificial intelligence (AI), including large language models and conversational tools, is increasingly being used in medical research.
These tools may assist researchers at different stages of the scientific process, such as generating research ideas, reviewing the literature, analyzing data, writing manuscripts, and preparing articles for publication.
While interest in AI is growing rapidly, there is still limited information on how these tools are actually perceived and used by leading medical researchers.
This study aims to better understand the attitudes, perceptions, and self-reported uses of artificial intelligence among corresponding authors who have published in six major international medical journals.
These authors play a key role in shaping scientific standards and editorial practices, and their views are essential to understanding how AI may influence the future of medical research.
Participants are invited to complete an anonymous online questionnaire that asks about their familiarity with AI tools, how and when they use or plan to use them in the research process, the potential benefits they perceive, and the concerns or limitations they identify.
The survey also explores participants' expectations regarding transparency, ethical guidance, and journal policies related to the use of artificial intelligence in scientific work.The study is observational and does not involve any medical intervention or collection of personal or health-related data.
Participation is voluntary, and responses are fully anonymous.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alpes Maritimes
-
Nice, Alpes Maritimes, France, 06000
- CHU de Nice
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
The study population consists of corresponding authors who have published scientific articles in leading international medical journals.
Participants are identified through publicly available publication data from six major journals (The New England Journal of Medicine, The Lancet, JAMA, Nature, Science, and The BMJ) and are invited to participate via professional email addresses.
The population includes adult researchers from diverse biomedical and medical disciplines, with no geographic restriction.
Description
Inclusion Criteria:
- Participants without any disease, condition, or related symptoms are permitted to participate. This study is a non-clinical, observational survey focusing on attitudes and practices related to artificial intelligence in scientific research, not on health conditions.
Exclusion Criteria:
- Authors who are not corresponding authors.
- Students, residents, interns, or trainees without corresponding author status.
- Individuals not involved in biomedical or medical research activities.
- Individuals who decline to participate or do not complete the online questionnaire.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Authors Survey Group
This label identifies the single cohort of participants, consisting of corresponding authors invited to complete the anonymous online survey.
No comparison or control groups are included.
|
This is an observational, non-interventional study based on an anonymous online questionnaire.
No intervention is administered to participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported attitudes regarding the use of artificial intelligence in the scientific research process
Time Frame: At the inclusion
|
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items.
Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
|
At the inclusion
|
|
Perceptions regarding the use of artificial intelligence in the scientific research process
Time Frame: At the inclusion
|
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items.
Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
|
At the inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported patterns of use, regarding artificial intelligence tools in scientific research and publishing
Time Frame: At the inclusion
|
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items.
Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
|
At the inclusion
|
|
Perceived benefits regarding artificial intelligence tools in scientific research and publishing
Time Frame: At the inclusion
|
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items.
Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
|
At the inclusion
|
|
Risk regarding artificial intelligence tools in scientific research and publishing
Time Frame: At the inclusion
|
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items.
Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
|
At the inclusion
|
|
Expectations regarding artificial intelligence tools in scientific research and publishing
Time Frame: At the inclusion
|
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items.
Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
|
At the inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 10, 2025
Primary Completion (Estimated)
March 10, 2026
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
December 24, 2025
First Submitted That Met QC Criteria
December 24, 2025
First Posted (Actual)
January 8, 2026
Study Record Updates
Last Update Posted (Actual)
January 8, 2026
Last Update Submitted That Met QC Criteria
December 24, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 25Chirplast02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Artificial Intelligence
-
Uşak UniversityCompletedDigital Competences | Artificial Intelligence (AI) | Physiotherapist Students | Acceptance of Artificial Intelligence | Artificial Intelligence AttitudeTurkey
-
University of YalovaNot yet recruitingArtificial Intelligence | Nursing Education | Clinical Competence | Artificial Intelligence (AI) | Nursing Process | Nursing Process Competence | Artificial Intelligence Perception and AttitudeTurkey (Türkiye)
-
Cambridge Health AllianceEnrolling by invitationAI (Artificial Intelligence) | Large Language Model | Generative Artificial IntelligenceUnited States
-
John J ChenCompletedCommunication | Interdisciplinary Communication | Artificial Intelligence (AI) | Artificial Intelligence TechnologyUnited States
-
Radboud University Medical CenterPrime Dental Alliance EindhovenNot yet recruitingArtificial Intelligence Supported Image Reviewing | Artificial Intelligence (AI) in DiagnosisNetherlands
-
Tanta UniversityNot yet recruitingArtificial Intelligence
-
Recep Tayyip Erdogan UniversityCompleted
-
Istituto Clinico HumanitasCompletedArtificial IntelligenceItaly
-
Istituto Clinico HumanitasCompletedArtificial IntelligenceItaly
-
Second Affiliated Hospital, School of Medicine,...UnknownArtificial IntelligenceChina
Clinical Trials on observational survey
-
Clinical Nutrition Research Centre, SingaporePrince September Pte Ltd SingaporeCompletedNutrition, HealthySingapore
-
Kilis 7 Aralik UniversityCompletedNurse-Patient Relations | Violence | Violence, PhysicalTurkey
-
Oğuzhan KandemirRecruitingFibromyalgia Syndrome | ChronotypeTurkey
-
Modum BadUniversity of OsloCompletedLoneliness, Worry, Rumination, Health Anxiety, Depression, AnxietyNorway
-
University of TorontoOntario Ministry of Health and Long Term CareUnknownHeart Failure | Chronic Obstructive Pulmonary DiseaseCanada
-
Medical University of LublinErasmus Medical Center; Jagiellonian University; Ohio State University; Poznan...RecruitingGastric Cancer | Malnutrition | Gastric Adenocarcinoma | CachexiaPoland
-
Albert Einstein College of MedicineNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsRecruitingLung Diseases | Lung Diseases, Obstructive | Lung Cancer | Lung Diseases, Interstitial | Lung InflammationUnited States
-
Johnson & Johnson Taiwan LtdCompletedAttention Deficit Disorder With Hyperactivity
-
Universitätsklinikum Hamburg-EppendorfCompletedOral Surgery | Maxillofacial SurgeryGermany
-
AmgenCompleted